Chronic myeloid leukemia (CML) is a stem cell disease in which BCR/ABL plays an important role as an oncoprotein and a molecular and immunogenic target. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.